Singapore-based biopharmaceutical company Tessa Therapeutics has raised an $80-million financing round led by Singapore state investor Temasek Holdings, EDBI, Karst Peak Capital, Heliconia Capital Management, Heritas and other investors.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
